After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, BDTX falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Black Diamond Therapeutics Inc is $145.43M. A total of 0.41 million shares were traded on the day, compared to an average of 1.18M shares.
In the most recent transaction, Versant Venture Capital VI, L. sold 221,600 shares of BDTX for 6.32 per share on Aug 28 ’24. After the transaction, the 10% Owner now owns 3,726,341 company shares. In a previous transaction on Jul 31 ’24, David Epstein bought 50,000 shares at 6.20 per share.
Among the insiders who bought shares, David Epstein acquired of 50,000 shares on Jul 26 ’24 at a per-share price of $6.20.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, BDTX has a high of $7.66 and a low of $2.15.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. BDTX’s latest balance sheet shows that the firm has $209.79M in Cash & Short Term Investments as of fiscal 2021. There were $28.46M in debt and $23.64M in liabilities at the time. Its Book Value Per Share was $1.72, while its Total Shareholder’s Equity was $195.90M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BDTX is Buy with a score of 4.86.
